Friday, February 17, 2017 12:25:40 PM
Remember MSTX had no debt, in fact has over 20 million in cash to use on future testing. Along with this fact their loan drug is getting already about approximately 80% financed through the government.
Say MSTX has 200 million shares.
So you have 2000 shares of mstx at .20 cents values at $400
There is a 20/1 Reverse Split where now you have only 100 shares at $4.00 valued at a total of still $400.
Rather than 200 million shares there is only 20 million now.
If you have a private company and own one share of Savara at $4.00 you are voting on how many shares it increses (one now is 1.2, 1.5, 1.7?). So your $4.00 now $4.50 or $5.00.
You have 2 companies combining pipelines (MSTX 1, Savara 4) drug possibilities with market financing.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM